Nasus Pharma Ltd (NSRX) IPO - S-1 Filing, Stock & Insider Activity

Nasus Pharma Ltd IPO - Status & S-1 Filing

Track every registration update on the InsiderAlpha IPO tracker.

Last SEC filing

Nasus Pharma Ltd (NSRX) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-29. Insiders disclosed 1 open-market purchases totaling $20K. InsiderAlpha tracks every NSRX SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.

About Nasus Pharma Ltd (NSRX)

Nasus Pharma Ltd trades under the ticker NSRX. InsiderAlpha tracks 4 primary SEC Form 4 filings from 1 reporting insider for NSRX since 2026, sourced directly from SEC EDGAR.

SEC CIK0002029039

90-Day SEC Filing Activity

Insider purchases (90d)1 ($20K)
Form 4 filings (90d)2
Latest Form 4 filing2026-07-29

Recent NSRX Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Dan Benjamin TelemanChief Executive OfficerP - Open-market purchase6.5K$3.10$20KSEC
Dan Benjamin TelemanChief Executive OfficerP - Open-market purchase2.9K$3.76$11KSEC
Dan Benjamin TelemanChief Executive OfficerP - Open-market purchase15.0K$2.04$31KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Nasus Pharma Ltd (NSRX). Updated in real time as new filings are submitted to the SEC.

Most-Active NSRX Insiders - Last 90 Days

InsiderForm 4 filingsTotal transaction value
Dan Benjamin Teleman2$20K

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NSRX insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

NSRX Insider Trading - FAQ

What is the latest insider trade for NSRX?
Nasus Pharma Ltd (NSRX) had 2 insider filings in the last 90 days, with the most recent on 2026-07-29. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying NSRX stock?
1 insider purchase of NSRX was filed in the last 90 days, totaling $20K.
How many insiders are selling NSRX stock?
0 insider sales of NSRX were filed in the last 90 days.
Where can I see NSRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks NSRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Companies with Insider Activity

Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:

Learn More

Open the live NSRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.